THALYS MEDICAL TECHNOLOGY GROUP CORPORATION

Thalys Medical Technology Group Corporation

603716

CNE1000030C3

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
7.27 ^CNY	+6.13%		+16.69%	-34.45%

Apr. 26	Thalys Medical Technology Group Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 26	Thalys Medical Technology Group Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Thalys Medical Technology's Controlling Shareholder Plans to Sell 5% Stake

November 04, 2021 at 07:43 am EDT

Thalys Medical Technology Group Inc. (SHSE:603716) said controlling shareholder plans to sell 5.0% stake in the Company for CNY 139.7 million ($21.84 million).

Latest news about Thalys Medical Technology Group Corporation

Thalys Medical Technology Group Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Thalys Medical Technology Group Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
Tranche Update on Thalys Medical Technology Group Corporation's Equity Buyback Plan announced on February 6, 2024.	Apr. 01	CI
Lin Zhonggang agreed to acquire a 43.5% stake in Heilongjiang Thalys Medical Technology Co., Ltd. from Thalys Medical Technology Group Corporation for CNY 1.5 million	Mar. 06	CI
An undisclosed buyer acquired a 51% stake in Guangdong Thalys Medical Technology Co., Ltd. Thalys Medical Technology Group Corporation	Mar. 06	CI
An unknown buyer acquired 51% stake in Chengdu Thalys Medical Technology Co., Ltd. from Thalys Medical Technology Group Corporation for CNY 1.02 million.	Mar. 06	CI
An undisclosed buyer acquired 51% stake in Shanxi Thalys Medical Technology Co., Ltd. from Thalys Medical Technology Group Corporation for CNY 1.53 million.	Mar. 06	CI
Shanxi Tianli Hengde Pharmaceutical Technology Co., Ltd. signed an equity transfer agreement to acquire 51% stake in Shanxi Jianghe Tonghui Medical Equipment Co., Ltd. from Thalys Medical Technology Group Corporation for CNY 0.55 million.	Mar. 06	CI
Thalys Medical Technology Group Corporation announces an Equity Buyback for CNY 20 million worth of its shares.	Feb. 05	CI
Thalys Medical Technology Group Corporation authorizes a Buyback Plan.	Feb. 04	CI
Thalys Medical Technology Group Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-10	CI
Thalys Medical Technology Group Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Thalys Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Factbox-Unions vs Macron: French pension strikes snarl trains, close schools	23-01-19	RE
Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. completed the acquisition of a 6.88% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd.	23-01-04	CI
Angze Taiying No. 6 Private Equity Securities Investment, managed by Shanghai Angze Private Fund Management Co., Ltd. signed Share Transfer Agreement to acquire 6.88% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd. for CNY 160 million.	22-12-15	CI
Thalys Medical Technology Group Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Thalys Medical Technology Group Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15	CI
Huang Jianfeng completed the acquisition of Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd.	22-08-09	CI
Huang Jianfeng signed a Share Transfer Agreement to acquire a 5.99% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd. for approximately CNY 150 million.	22-07-25	CI
Thalys Medical Technology Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Thalys Medical Technology Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-25	CI
Genetic Analysis AS and Thalys Medical Technology Group Enters Microbiome Laboratory Developed Test Agreement for the Chinese Market	22-01-13	CI
Yanfeng Sunflower No. 1 Private Equity Securities Investment Fund managed by Shanghai Yanfeng Investment Management Co., Ltd completed the acquisition of 5% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd.	21-11-17	CI
Yanfeng Sunflower No. 1 Private Equity Securities Investment Fund managed by Shanghai Yanfeng Investment Management Co., Ltd signed a share transfer agreement to acquire 5% stake in Thalys Medical Technology Group Inc. from Saihai Health Technology Co., Ltd. for CNY 140 million.	21-11-04	CI

Chart Thalys Medical Technology Group Corporation

Duration

Period

Chart Thalys Medical Technology Group Corporation

More charts

Thalys Medical Technology Group Corp, formerly Thalys Medical Technology Inc, is a China-based company principally engaged in the provision of intensified distribution business and simple sales business and the research, design, manufacture and distribution of independent in vitro diagnostic products. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The Company mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-15 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Equipment Wholesale

	1st Jan change	Capi.
THALYS MEDICAL TECHNOLOGY GROUP CORPORATION	-34.45%	181M
HENRY SCHEIN, INC.	-3.54%	9.4B
OWENS & MINOR, INC.	+31.91%	1.92B
SHIP HEALTHCARE HOLDINGS, INC.	-2.66%	1.39B
AS ONE CORPORATION	-6.07%	1.18B
GKHT MEDICAL TECHNOLOGY CO., LTD.	-16.69%	856M
TOKAI CORP.	+0.77%	470M
EXCELSIOR MEDICAL CO., LTD.	+3.39%	437M
GAUSH MEDITECH LTD	-48.68%	360M
COWEALTH MEDICAL CHINA CO.,LTD.	-22.36%	333M